Kamada Ltd. Share Price TEL AVIV STOCK EXCHANGE
Stocks
KMDA
IL0010941198
Pharmaceuticals
| Market Cap | 1.25B 423M 366M 344M 312M 587M 40.48B 597M 4.03B 1.57B 20.27B 1.59B 1.55B 67.36B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.25B 423M 366M 344M 312M 587M 40.48B 597M 4.03B 1.57B 20.27B 1.59B 1.55B 67.36B | EV / Sales 2026 * |
2.06x | EV / Sales 2027 * | 1.85x |
| Free-Float |
54.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kamada Ltd.
| 1 day | +3.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 58 | 30/06/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 56 | 30/12/2017 |
Eran Nir
COO | Chief Operating Officer | 54 | 31/10/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
David Tsur
BRD | Director/Board Member | 75 | 12/12/1990 |
Leon Recanati
CHM | Chairman | 77 | 06/03/2013 |
| Chairman | 55 | 11/08/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.07% | +4.32% | - | - | 423M | |
| -0.31% | +2.44% | +38.43% | -0.30% | 80.23B | |
| -1.02% | -0.51% | -2.54% | +26.80% | 50.64B | |
| -3.10% | -4.84% | +10.29% | +158.34% | 46.87B | |
| -0.74% | +3.26% | -49.51% | -49.96% | 46.34B | |
| -0.39% | +0.91% | +51.39% | -22.35% | 31B | |
| -0.52% | +7.01% | +125.98% | -34.32% | 25.28B | |
| -0.30% | -0.33% | +38.24% | +83.70% | 24.36B | |
| -1.42% | -1.11% | -3.79% | +190.40% | 20.81B | |
| -1.83% | -2.82% | +60.85% | +107.54% | 16.08B | |
| Average | -0.66% | +1.44% | +29.93% | +51.09% | 37.96B | |
| Weighted average by Cap. | -1.01% | +1.13% | +22.69% | +36.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 608M 206M 178M 167M 152M 285M 19.66B 290M 1.95B 764M 9.84B 772M 755M 32.71B | 676M 229M 197M 186M 169M 317M 21.86B 322M 2.17B 850M 10.95B 858M 840M 36.38B |
| Net income | 85.01M 28.76M 24.84M 23.34M 21.23M 39.92M 2.75B 40.57M 274M 107M 1.38B 108M 106M 4.58B | 104M 35.34M 30.52M 28.68M 26.08M 49.04M 3.38B 49.85M 336M 131M 1.69B 133M 130M 5.62B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
